Neurology News

Concerns about potential malpractice liability are top of mind for many physicians of all specialties. This is not surprising given recent verdicts in medical malpractice actions that have awarded millions of dollars in damages to plaintiffs.

Patients with autoimmune diseases or long COVID who used a personalized digital care program alongside other non-pharmacologic strategies were more likely to achieve better health-related quality of life scores, according to data.

BOSTON – Diversity in the medical profession is crucial, and tapping into underrepresented populations to achieve that goal with a solid foundation of mentorship is key, according to Alyx B. Porter, MD, in this Healio video.

Prothena Corporation plc announced Bristol Myers Squibb exercised its option under its global neuroscience research and development collaboration to obtain exclusive worldwide commercial rights for PRX005, paying Prothena $55 million.

In football-playing males, the number and force of repetitive head injuries as well as time playing the sport were linked to severity of chronic traumatic encephalopathy, according to research published in Nature Communications.

The FDA has approved an expanded indication for a proprietary neurostimulation technology to treat those with severe obstructive sleep apnea.

Many states have corporate practice of medicine prohibitions.

Older adults that suffer with hypoxemia while sleeping showed decreased measures of cognition over a 5-year period, according to study results published in European Respiratory Journal.

Patients with rheumatoid arthritis demonstrate a nearly 1.5-fold increased risk for developing Parkinson’s disease vs. those without RA, according to data published in JAMA Neurology.

President Joe Biden announced new proposals that aim to lower health care costs by reinstating limits on short-term insurance plans and addressing surprise medical bills and medical debt.